Creative Medical Technology (CELZ) announced initial data from the first cohort of its ongoing Phase 1/2 clinical trial of CELZ-201-DDT, the ...
FDA approved Ryoncil ® as the first and only therapy for pediatric patients 2 months and older, including adolescents and teenagers, with steroid-refractory acute graft versus host disease (SR-aGvHD), ...
Chronic Pain, that persists beyond the usual recovery period or occurs along with a chronic health condition, such as arthritis. The rising prevalence of chronic pain drives market growth by ...
The global electric wheelchairs market size was valued at USD 4.35 billion in 2024 and is projected to reach from USD 4.87 ...
The responses of disabled people who answered a question about the likely impact of expected government cuts to disability benefits have revealed a worrying level of “fear and desperation”, say ...
Lower back pain is most common in women and is caused by several reasons such as hormonal changes, spine osteoarthritis, ...